Emagin (EMAN) 10-K 13 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Jan. 31, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Registrant Name	EMAGIN CORP
Entity Central Index Key	1046995
Entity Filer Category	Smaller Reporting Company
Current Fiscal Year End Date	-19
Entity Public Float			$36.90
Entity Common Stock, Shares Outstanding		25,195,107
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$5,290	$4,032
Investments	750	6,250
Accounts receivable, net	4,044	4,319
Inventories, net	4,586	3,434
Prepaid expenses and other current assets	656	745
Total current assets	15,326	18,780
Long-term investments		750
Equipment, furniture and leasehold improvements, net	9,417	9,119
Intangibles and other assets	382	27
Total assets	25,125	28,676
Current liabilities:
Accounts payable	1,027	1,470
Accrued compensation	1,145	1,155
Other accrued expenses	812	1,436
Advance payment	74	155
Deferred revenue	331	66
Other current liabilities	664	395
Total current liabilities	4,053	4,677
Commitments and contingencies (Note 11)
Shareholders' equity:
Preferred stock, $.001 par value: authorized 10,000,000 shares: Series B Convertible Preferred stock, (liquidation preference of $5,659,000) stated value $1,000 per share, $.001 par value: 10,000 shares designated and 5,659 issued and outstanding as of December 31, 2014 and December 31, 2013
Common stock, $.001 par value: authorized 200,000,000 shares, issued and outstanding, 25,195,107 shares as of December 31, 2014 and 23,928,619 as of December 31, 2013	25	24
Additional paid-in capital	228,380	226,051
Accumulated deficit	-206,833	-201,576
Treasury stock, 162,066 shares as of December 31, 2014 and 2013	-500	-500
Total shareholders' equity	21,072	23,999
Total liabilities and shareholders' equity	$25,125	$28,676

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	25,195,107	23,928,619
Common stock, shares outstanding	25,195,107	23,928,619
Treasury stock, shares	162,066	162,066
Series B Convertible Preferred Stock [Member]
Preferred stock, par value	$0.00	$0.00
Preferred stock - Series B, liquidation preference	$5,659,000	$5,659,000
Preferred stock, stated value	$1,000	$1,000
Preferred stock, shares issued	5,659	5,659
Preferred stock, shares outstanding	5,659	5,659
Designated Series B Convertible Preferred Stock, shares	10,000	10,000

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Revenue:
Product	$24,061	$26,315
Contract	1,654	1,675
Total revenue, net	25,715	27,990
Cost of goods sold:
Product	17,384	18,573
Contract	946	991
Total cost of goods sold	18,330	19,564
Gross profit	7,385	8,426
Operating expenses:
Research and development	4,511	5,023
Selling, general and administrative	8,125	8,605
Total operating expenses	12,636	13,628
Loss from operations	-5,251	-5,202
Other income (expense):
Interest expense, net	-28	-31
Other income, net	22	50
Total other income (expense), net	-6	19
Loss before provision for income taxes	-5,257	-5,183
Provision for income taxes		8,884
Net loss	($5,257)	($14,067)
Loss per share, basic	($0.22)	($0.60)
Loss per share, diluted	($0.22)	($0.60)
Weighted average number of shares outstanding:
Basic	24,376,259	23,639,554
Diluted	24,376,259	23,639,554

Consolidated_Statements_Of_Cha

Consolidated Statements Of Changes In Shareholders' Equity (USD $)	Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
In Thousands, except Share data		USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Balance at Dec. 31, 2012		$24	($463)	$223,575	($187,509)	$35,627
Balance, shares at Dec. 31, 2012	5,659	23,674,541	-150,000
Exercise of common stock options				394		394
Exercise of common stock options, shares		254,078				254,078
Stock-based compensation				2,082		2,082
Purchase of treasury stock			-37			-37
Purchase of treasury stock, shares			-12,066
Net loss					-14,067	-14,067
Balance at Dec. 31, 2013		24	-500	226,051	-201,576	23,999
Balance, shares at Dec. 31, 2013	5,659	23,928,619	-162,066
Exercise of common stock options				275		275
Exercise of common stock options, shares		266,488				266,488
Exercise of common stock warrants		1		1,029		1,030
Exercise of common stock warrants, shares		1,000,000
Stock-based compensation				1,025		1,025
Net loss					-5,257	-5,257
Balance at Dec. 31, 2014		$25	($500)	$228,380	($206,833)	$21,072
Balance, shares at Dec. 31, 2014	5,659	25,195,107	-162,066

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	($5,257)	($14,067)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,181	905
Increase (reduction) in provision for doubtful accounts	582	-86
Amortization of bond premium		20
Inventory reserve	202	24
Stock-based compensation	1,025	2,082
Loss (gain) on sale of asset	8	-9
Deferred income taxes		8,881
Changes in operating assets and liabilities:
Accounts receivable	-307	922
Inventories, net	-1,355	-235
Prepaid expenses and other current assets	8
Advance payments	-81	83
Deferred revenue	265	6
Accounts payable, accrued compensation, accrued expenses, and other current liabilities	-957	676
Net cash used in operating activities	-4,686	-798
Cash flows from investing activities:
Purchase of equipment	-1,479	-1,927
Proceeds from sale of asset	8	15
Purchase of intangibles	-140
Maturities of investments	8,250	14,000
Purchase of investments	-2,000	-12,000
Net cash provided by investing activities	4,639	88
Cash flows from financing activities:
Proceeds from exercise of stock options and warrants	1,305	394
Purchase of treasury stock		-37
Net cash provided by financing activities	1,305	357
Net increase (decrease) in cash and cash equivalents	1,258	-353
Cash and cash equivalents, beginning of period	4,032	4,385
Cash and cash equivalents, end of period	5,290	4,032
Cash paid for interest, net of amount capitalized of $13 and $11 thousand in 2014 and 2013, respectively		1
Cash paid for taxes		101
Non-cash investing activities [Abstract]
Intangible assets - patents	$150

Consolidated_Statements_Of_Cas1

Consolidated Statements Of Cash Flows (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements Of Cash Flows [Abstract]
Capitalized interest	$13	$11

Nature_Of_Business

Nature Of Business	12 Months Ended
	Dec. 31, 2014
Nature Of Business [Abstract]
Nature Of Business
	Note 1 - Nature Of Business
	eMagin Corporation and its wholly owned subsidiary (the “Company”) designs, manufactures and supplies OLED-on-silicon microdisplays and virtual imaging products which utilize OLED microdisplays. The Company’s products are sold mainly in North America, Asia, and Europe.

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies [Abstract]
Significant Accounting Policies
	Note 2:   Significant Accounting Policies
	Principles of consolidation
	The accompanying consolidated financial statements include the accounts of eMagin Corporation and its wholly owned subsidiary.  All intercompany transactions have been eliminated in consolidation.
	Use of estimates
	In accordance with accounting principles generally accepted in the United States of America, management utilizes certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments related to, among others, allowance for doubtful accounts, warranty reserves, inventory reserves, stock-based compensation expense, deferred tax asset valuation allowances, fair value of financial instruments, litigation and other loss contingencies. Management bases its estimates and judgments on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.
	Revenue and cost recognition
	Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, selling price is fixed or determinable and collection is reasonably assured.   Product revenue is generally recognized when products are shipped to customers.
	The Company also earns revenues from certain research and development (“R&D”) activities (contract revenues) under both firm fixed-price contracts and cost-type contracts.  Revenues relating to firm fixed-price contracts and cost-type contracts are generally recognized on the percentage-of-completion method of accounting as costs are incurred (cost-to-cost basis).  Progress is generally based on a cost-to-cost approach however an alternative method may be used such as physical progress, labor hours or others depending on the type of contract.   Physical progress is determined as a combination of input and output measures as deemed appropriate by the circumstances.  Contract costs include all direct material and labor costs and an allocation of allowable indirect costs as defined by each contract, as periodically adjusted to reflect revised agreed upon rates. These rates are subject to audit by the other party.
	Product warranty
	The Company offers a one-year product replacement warranty. In general, the standard policy is to repair or replace the defective products. The Company accrues for estimated returns of defective products at the time revenue is recognized based on historical activity as well as for specific known product issues. The determination of these accruals requires the Company to make estimates of the frequency and extent of warranty activity and estimate future costs to replace the products under warranty. If the actual warranty activity and/or repair and replacement costs differ significantly from these estimates, adjustments to cost of revenue may be required in future periods.
	The following table provides a summary of the activity related to the Company's warranty liability, included in other current liabilities, during the years ended December 31, 2014 and 2013 (in thousands):
		For the Year Ended
		December 31,
		2014			2013
	Beginning balance	$	394		$	276
	Warranty accruals		760			425
	Warranty usage		-491			-307
	Ending balance	$	663		$	394
	Research and development expenses
	Research and development costs are expensed as incurred.
	Cash and cash equivalents
	All highly liquid instruments with an original maturity of three months or less at the date of purchase are considered to be cash equivalents.
	Investments
	Investments consist of FDIC-insured certificates of deposit which the Company classifies as held-to-maturity since it has the positive intent and ability to hold them until maturity and the investments are carried at amortized cost.  As of December 31, 2014 and 2013, the held-to-maturity investments were $0.75 million and $7 million, respectively, maturing within 6 months and 18 months, respectively.
	Accounts receivable
	The majority of the Company’s commercial accounts receivable are due from Original Equipment Manufacturers ("OEM’s”). Credit is extended based on an evaluation of a customer’s financial condition and, generally, collateral is not required. Accounts receivable are payable in U.S. dollars, are due within 30-90 days and are stated at amounts due from customers net of an allowance for doubtful accounts. Any account outstanding longer than the contractual payment terms is considered past due.
	Allowance for doubtful accounts
	The allowance for doubtful accounts reflects an estimate of probable losses inherent in the accounts receivable balance. The allowance is determined based on a variety of factors, including the length of time receivables are past due, historical experience, the customer's current ability to pay its obligation, and the condition of the general economy and the industry as a whole.  The Company will record a specific reserve for individual accounts when the Company becomes aware of a customer's inability to meet its financial obligations, deterioration in the customer's operating results or financial position, or deterioration in the customer’s credit history. If circumstances related to customers change, the Company would further adjust estimates of the recoverability of receivables.  Account balances, when determined to be uncollectible, are charged against the allowance.
	Inventory
	Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out method. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. The Company regularly reviews inventory quantities on hand, future purchase commitments with the Company’s suppliers, and the estimated utility of the inventory. If the Company review indicates a reduction in utility below carrying value, the inventory is reduced to a new cost basis.
	Equipment, furniture and leasehold improvements
	Equipment, furniture and leasehold improvements are stated at cost. Depreciation on equipment is calculated using the straight-line method of depreciation over its estimated useful life. Amortization of leasehold improvements is calculated by using the straight-line method over the shorter of their estimated useful lives or lease terms. Expenditures for maintenance and repairs are charged to expense as incurred.
	The Company performs impairment tests on its long-lived assets when circumstances indicate that their carrying amounts may not be recoverable. If required, recoverability is tested by comparing the estimated future undiscounted cash flows of the asset or asset group to its carrying value. Impairment losses, if any, are recognized based on the excess of the assets' carrying amounts over their estimated fair values.
	Intangible assets
	The Company’s intangible assets are patents that are recorded at purchase price as of the date acquired and amortized over the expected useful life which is generally the remaining life of the patent.  During 2014, the Company purchased several patents for $290 thousand which will be amortized over their remaining useful life.  The net book value of all intangible assets was $301 thousand at December 31, 2014.  The accumulated amortization as of December 31, 2014 was $54 thousand.  As of December 31, 2014, the weighted average remaining useful life of the patents was approximately 6.9 years.
	Total intangible amortization expense was approximately $16 thousand and $4 thousand for each of the years ended December 31, 2014 and 2013, respectively.   Estimated amortization expense for the next five years, beginning with 2015, is as follows:  $58 thousand, $54 thousand, $54 thousand, $54 thousand, $32 thousand and thereafter, $49 thousand.
	Advertising
	Costs related to advertising and promotion of products are charged to sales and marketing expense as incurred.  There was no  advertising expense for the years ended December 31, 2014 and 2013.
	Shipping and handling fees
	The Company includes costs related to shipping and handling in cost of goods sold.
	Income taxes
	The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.  The effect on deferred tax assets and liabilities of changes in tax rates will be recognized as income or expense in the period that the change occurs.  A valuation allowance for deferred tax assets is recorded when it is more likely than not that some or all of the benefit from the deferred tax asset will not be realized.  Changes in circumstances, assumptions and clarification of uncertain tax regimes may require changes to any valuation allowances associated with the Company’s deferred tax assets.
	Due to the Company’s operating loss carryforwards, all tax years remain open to examination by the major taxing jurisdictions to which the Company is subject. In the event that the Company is assessed interest or penalties at some point in the future, it will be classified in the financial statements as tax expense.
	Income (loss) per common share
	Basic income (loss) per share (“Basic EPS”) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period.  Diluted income (loss) per share (“Diluted EPS”) is computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the reporting period while also giving effect to all potentially dilutive common shares that were outstanding during the reporting period.
	In accordance with ASC 260, entities that have issued securities other than common stock that participate in dividends with the common stock (“participating securities”) are required to apply the two-class method to compute basic EPS.  The two-class method is an earnings allocation method under which EPS is calculated for each class of common stock and participating security as if all such earnings had been distributed during the period.  On December 22, 2008, the Company issued Convertible Preferred Stock – Series B which participates in dividends with the Company’s common stock and is therefore considered to be a participating security. The participating convertible preferred stock is not required to absorb any net loss.  The Company uses the more dilutive method of calculating the diluted earnings per share, either the two class method or “if-converted” method.  Under the “if-converted” method, the convertible preferred stock is assumed to have been converted into common shares at the beginning of the period.
	For the years ended December 31, 2014 and 2013, the Company reported a net loss and as a result, basic and diluted loss per common share are the same. Therefore, in calculating net loss per share amounts, shares underlying the potentially dilutive common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive.
	The following is a table of the potentially dilutive common stock equivalents for the years ended December 31, 2014 and 2013 that were not included in diluted EPS as their effect would be anti-dilutive:
		For the Years Ended December 31,
		2014		2013
	Options	4,510,107		4,597,186
	Warrants	—		1,000,000
	Convertible preferred stock	7,545,333		7,545,333
	Total potentially dilutive common stock equivalents	12,055,440		13,142,519
	Comprehensive income (loss)
	Comprehensive income (loss) refers to net income (loss) and other revenue, expenses, gains and losses that, under generally accepted accounting principles, are recorded as an element of shareholders’ equity but are excluded from the calculation of net income (loss).
	The Company's operations did not give rise to any material items includable in comprehensive income (loss), which were not already in net income (loss) for the years ended December 31, 2014 and 2013. Accordingly, the Company's comprehensive income (loss) is the same as its net income (loss) for the periods presented.
	Stock-based compensation
	The Company uses the fair value method of accounting for share-based compensation arrangements. The fair values of stock options are estimated at the date of grant using the Black-Scholes option valuation model. Stock-based compensation expense is reduced for estimated forfeitures and is amortized over the vesting period using the straight-line method.
	Concentration of credit risk
	The majority of eMagin’s products are sold throughout North America, Asia, and Europe.  Sales to the Company’s recurring customers are generally made on open account while sales to occasional customers are typically made on a prepaid basis.  eMagin performs periodic credit evaluations on its recurring customers and generally does not require collateral.  An allowance for doubtful accounts is maintained for credit losses.
	Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and short-term and long-term investments.  The Company’s cash and cash equivalents are deposited with financial institutions which, at times, may exceed federally insured limits.  The Company has funds invested in a money market account which are not insured.  The Company has Certificates of Deposits (“CDs”) classified as short and long-term investments, which are federally insured. To date, the Company has not experienced any loss associated with this risk.
	Recently issued accounting standards
In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled when products are transferred to customers. ASU 2014-09 will be effective for the Company beginning January 1, 2017. Early adoption is not permitted. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. The Company is currently evaluating the impact of adopting the new revenue standard on its consolidated financial statements.

Accounts_Receivables_Net

Accounts Receivables, Net	12 Months Ended
	Dec. 31, 2014
Accounts Receivables, Net [Abstract]
Accounts Receivables, Net
	Note 3:  Accounts Receivable, net
	Accounts receivable consisted of the following (in thousands):
		December 31,
		2014		2013
	Accounts receivable	$	4,717	$	4,464
	Less allowance for doubtful accounts		-673		-145
	Accounts receivable, net	$	4,044	$	4,319

Inventories_Net

Inventories, Net	12 Months Ended
	Dec. 31, 2014
Inventories, Net [Abstract]
Inventories, Net	Note 4:  Inventories, net
	The components of inventories were as follows (in thousands):
		December 31,
		2014		2013
	Raw materials	$	2,506	$	1,905
	Work in process		1,086		987
	Finished goods		1,291		637
	Total inventories		4,883		3,529
	Less inventory reserve		-297		-95
	Total inventories, net	$	4,586	$	3,434

Prepaid_Expenses_And_Other_Cur

Prepaid Expenses And Other Current Assets	12 Months Ended
	Dec. 31, 2014
Prepaid Expense And Other Current Assets [Abstract]
Prepaid Expenses And Other Current Assets	Note 5 – Prepaid Expenses and Other Current Assets
	Prepaid expenses and other current assets consist of the following (in thousands):
		December 31,
		2014		2013
	Vendor prepayments	$	152	$	52
	Other prepaid expenses*		504		693
	Total prepaid expenses and other current assets	$	656	$	745
	*No individual amounts greater than 5% of current assets.

Equipment_Furniture_And_Leaseh

Equipment, Furniture And Leasehold Improvements	12 Months Ended
	Dec. 31, 2014
Equipment, Furniture And Leasehold Improvements [Abstract]
Equipment, Furniture And Leasehold Improvements	Note 6 – Equipment, Furniture and Leasehold Improvements
	Equipment, furniture and leasehold improvements consist of the following (in thousands):
		December 31,
		2014		2013
	Computer hardware and software	$	1,410	$	1,391
	Lab and factory equipment		13,084		10,760
	Furniture, fixtures and office equipment		344		329
	Assets under capital leases		66		66
	Construction in progress		1,905		2,801
	Leasehold improvements		473		473
	Total equipment, furniture and leasehold improvements		17,282		15,820
	Less:  accumulated depreciation		-7,865		-6,701
	Equipment, furniture and leasehold improvements, net	$	9,417	$	9,119
	Depreciation expense was $1.2 million and $900 thousand for the years ended December 31, 2014 and 2013, respectively.  Assets under capital leases are fully amortized.

Debt

Debt	12 Months Ended
	Dec. 31, 2014
Debt [Abstract]
Debt	Note 7– Debt
	For the years ended December 31, 2014 and 2013, interest expense includes interest paid, capitalized or accrued of approximately $42 thousand on outstanding debt.
	Line of Credit
	At December 31, 2014, the Company had available a credit facility with Access Business Finance, LLC (“Access”) under which the Company may borrow up to a maximum of $3 million based on a borrowing base equivalent of 75% of eligible accounts receivable.
	The terms of the line of credit are:  the minimum monthly interest payment is $1 thousand; the interest rate is Prime plus 4% but not less than 7.25%; and the early termination fee is $6 thousand. The renewal date of the line of credit is September 1, 2015.
	In 2014 and 2013, the Company paid  $30 thousand in loan fees to Access which were charged to prepaid expense and amortized over the life of the agreement.  The Company’s obligations under the agreement are secured by its assets.   As of December 31, 2014, the Company had not borrowed on its line of credit.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Income Taxes	Note 8 - INCOME TAXES
	Net loss before income taxes consists of the following (in thousands):
		For the Years Ended
		December 31,
		2014			2013
	Domestic	$	-5,257		$	-5,183
	Total	$	-5,257		$	-5,183
	The federal and state income tax provision is summarized as follows (in thousands):
		For the Years Ended
		December 31,
		2014			2013
	Current:	$			$
	Federal		-			1
	State		-			2
	Total current tax expense		-			3
	Deferred:
	Federal		-			8,803
	State		-			78
	Total deferred tax expense		-			8,881
	Total tax expense	$	-		$	8,884
	Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and (b) operating losses and tax credit carryforwards.
	The tax effects of significant items comprising the Company’s deferred taxes as of December 31 are as follows (numbers are in thousands):
		For the Years Ended
		December 31,
		2014			2013
	Deferred tax assets:
	Federal and state net operating loss carryforwards	$	37,635		$	36,284
	Research and development tax credit carryforwards		2,214			1,979
	Stock based compensation		3,922			3,665
	Other provision and expenses not currently deductible		1,093			755
	Total deferred tax assets		44,864			42,683
	Deferred tax liabilities:
	Depreciation and amortization		-682			-374
	Prepaid expenses		-145			-191
	Total deferred liabilities		-827			-565
	Less valuation allowance		-44,037			-42,118
	Net deferred tax asset	$	—		$	—
	The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.  The effect on deferred tax assets and liabilities of changes in tax rates will be recognized as income or expense in the period that the change occurs.  A valuation allowance for deferred tax assets is recorded when it is more likely than not that some or all of the benefit from the deferred tax asset will not be realized.  Changes in circumstances, assumptions and clarification of uncertain tax regimes may require changes to any valuation allowances associated with the Company’s deferred tax assets.
	In 2013, the Company determined that based on all available evidence, both positive and negative, and based on the weight of the available evidence, including the Company’s recent operating loss in 2013 and a projected cumulative loss through 2014, it was more likely than not that none of its deferred tax assets will be realized.  Therefore, it recorded a full valuation allowance and recorded income tax expense of $8.9 million.  In 2014, the Company had an operating loss and cumulative loss and it determined it is still more likely than not that none of its deferred tax assets would be realized and therefore it maintained a full valuation allowance.
	As of December 31, 2014 and 2013, the Company had net deferred tax assets before its valuation allowance of approximately $44 million and $42.1 million, respectively, primarily resulting from the future tax benefit of net operating loss carryforwards. The amount of the valuation allowance for deferred tax assets associated with excess tax deduction from stock-based compensation arrangement that is allocated to contributed capital if the future tax benefits are subsequently recognized is $1.3 million at December 31, 2014.
	During the year ended December 31, 2014, the Company did not utilize its prior years’ net operating loss carryforwards.   As of December 31, 2014, eMagin has federal and state net operating loss carryforwards of approximately $114.1 million and $1.2 million, respectively. The federal research and development tax credit carryforwards are approximately $2.2 million. The federal net operating losses and tax credit carryforwards will expire as follows:
			Net			Research and
			Operating			Development
			Losses			Tax Credits
		(in millions)
	2018-2021	$	44.6		$	0.8
	2022-2025		42.8			—
	2026-2034		26.7			1.4
		$	114.1		$	2.2
	The utilization of net operating losses is subject to a limitation due to the change of ownership provisions under Section 382 of the Internal Revenue Code and similar state provisions. Such limitation may result in the expiration of the net operating losses before their utilization. The Company has done an analysis regarding prior year ownership changes, and it has been determined that the Section 382 limitation on the utilization of net operating losses will currently not materially affect the Company's ability to utilize its net operating losses.
	The difference between the statutory federal income tax rate on the Company's pre-tax loss and the Company's effective income tax rate is summarized as follows:
		For the Years Ended
		December 31,
		2014			2013
	U.S. Federal income tax expense at federal statutory rate		34	%		34	%
	Change in valuation allowance		-37			-214
	Change in effective state tax rate		-2			1
	Credits		5			8
	Effective tax rate		—	%		-171	%
	The Company did not have unrecognized tax benefits at December 31, 2014 and 2013.  The Company recognizes interest accrued and penalties related to unrecognized tax benefits in tax expense.  During the years ended December 31, 2014 and 2013, the Company recognized no interest and penalties.
	The Company files income tax returns in the U.S. federal jurisdiction, California, Florida, and New York.  Due to the Company's operating losses, all tax years remain open to examination by major taxing jurisdictions to which the Company is subject.

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2014
Shareholders' Equity [Abstract]
Shareholders' Equity	Note 9:  Shareholders’ Equity
	Preferred Stock - Series B Convertible Preferred Stock (“the Preferred Stock – Series B”)
	The Company has designated 10,000 shares of the Company’s preferred stock as Preferred Stock – Series B at a stated value of $1,000 per share.  The Preferred Stock – Series B is convertible into common stock at a conversion price of $0.75 per share.   The holders of the Preferred Stock – Series B are not entitled to receive dividends unless the Company’s Board of Directors declare a dividend for holders of the Company’s common stock and then the dividend shall be equal to the amount that such holder would have been entitled to receive if the holder converted its Preferred Stock – Series B into shares of the Company’s common stock.  In the event of a liquidation, dissolution, or winding up of the Company, the Preferred Stock – Series B is entitled to receive liquidation preference before the Common Stock.  The Company may at its option redeem the Preferred Stock – Series B by providing the required notice to the holders of the Preferred Stock – Series B and paying an amount equal to $1,000 multiplied by the number of shares for all of such holder’s shares of outstanding Preferred Stock – Series B to be redeemed.
	As of December 31, 2014 and 2013, there were 5,659 shares of Preferred Stock – Series B issued and outstanding.
	Common Stock
	The Company received approximately $275 thousand and $394 thousand for the exercise of 266,488 and 254,078 stock options during the years ended December 31, 2014 and 2013, respectively.   For the year ended December 31, 2014, the Company received approximately $1.0 million from the exercise of 1 million warrants.  There were no warrants exercised during 2013.
	During the year ended December 31, 2014, the Company did not repurchase stock and during the year ended December 31, 2013, the Company repurchased 12,066 shares at an average cost of $2.99 per share.  At December 31, 2014, there was approximately $2.0 million remaining under the stock repurchase plan.

Stock_Compensation

Stock Compensation	12 Months Ended
	Dec. 31, 2014
Stock Compensation [Abstract]
Stock Compensation	Note 10:  Stock Compensation
	Employee stock purchase plan
	In 2005, the shareholders approved the 2005 Employee Stock Purchase Plan (“ESPP”).  The ESPP provides the Company’s employees with the opportunity to purchase common stock through payroll deductions. Employees may purchase stock semi-annually at a price that is 85% of the fair market value at certain plan-defined dates. At December 31, 2014, the number of shares of common stock available for issuance was 300,000.  As of December 31, 2014, the plan had not been implemented.
	Incentive compensation plans
	The Amended and Restated 2003 Employee Stock Option Plan (the  “2003 Plan”) provided for grants of shares of common stock and options to purchase shares of common stock to employees, officers, directors and consultants.   The 2003 Plan terminated July 2, 2013.  No additional options can be granted from the plan though options granted before the 2003 Plan terminated may be exercised until the grant expires.
	The 2008 Incentive Stock Plan (the “2008 Plan”) adopted and approved by the Board of Directors on November 5, 2008 provides for  grants of common stock and options to purchase shares of common stock to employees, officers, directors and consultants.  The 2008 Plan has an aggregate of 2 million shares.  In 2014, there were no options issued from the 2008 Plan.
	The 2011 Incentive Stock Plan (the “2011 Plan”) was approved by the Company’s shareholders on November 3, 2011.  The 2011 Plan provides for grants of common stock and options to purchase common stock to employees, officers, directors and consultants.  The Board of Directors reserved 1.4 million shares of common stock for issuance under the 2011 Plan. On June 7, 2012, at the Company’s Annual Meeting, the shareholders approved an Amended and Restated 2011 Incentive Stock Plan which eliminated the evergreen provision and prohibits the repricing or exchange of stock options without shareholder approval. In 2014, there were no options issued from the 2011 Plan.
	The 2013 Incentive Stock Plan (the “2013 Plan”) adopted and approved by the shareholders on May 17, 2013 provides for grants of common stock and options to purchase shares of common stock to employees, officers, directors and consultants.   The 2013 Plan has an aggregate of 1.5 million shares.  In 2014, there were 404,113 options granted from this plan.
	Vesting terms of the options range from immediate vesting to a ratable vesting period of 5 years. Option activity for the years ended December 31, 2014 and 2013 is summarized as follows:
		Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
	Outstanding at December 31, 2013		4,597,186		$	3.82
	Options granted		404,113			2.63
	Options exercised		-266,488			1.03
	Options forfeited		-109,055			3.89
	Options cancelled or expired		-115,649			5.84
	Outstanding at December 31, 2014		4,510,107		$	3.83		3.93	$	1,292,171
	Vested or expected to vest at December 31, 2014 (1)		4,493,527		$	3.83		3.93	$	1,291,519
	Exercisable at December 31, 2014		4,095,661		$	3.87		3.89	$	1,246,530
	(1) The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.
	At December 31, 2014, there were 1,369,464 shares available for grant under the 2013, 2011, and 2008 Plans.
	The aggregate intrinsic value in the table above represents the difference between the exercise price of the underlying options and the quoted price of the Company’s common stock on December 31, 2014 for the options that were in-the-money.  As of December 31, 2014 there were 1,337,104 options that were in-the-money.   The Company’s closing stock price was $2.32 as of December 31, 2014. The Company issues new shares of common stock upon exercise of stock options.  The intrinsic value of the 2014 options exercised was $0.4 million of which $0.2 million is an excess tax benefit.
	Stock- based compensation
	The Company uses the fair value method of accounting for share-based compensation arrangements. The fair value of stock options is estimated at the date of grant using the Black-Scholes option valuation model.  Stock-based compensation expense is reduced for estimated forfeitures and is amortized over the vesting period using the straight-line method.
	The following table summarizes the allocation of non-cash stock-based compensation to the Company’s expense categories for the years ended December 31, 2014 and 2013 (in thousands):
		For the Years Ended
		December 31,
		2014			2013
	Cost of revenue	$	154		$	285
	Research and development		262			566
	Selling, general and administrative		609			1,231
	Total stock compensation expense	$	1,025		$	2,082
	At December 31, 2014, total unrecognized compensation costs related to stock options was approximately $0.4 million, net of estimated forfeitures.  Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures and is expected to be recognized over a weighted average period of approximately 1.3 years.
	The following key assumptions were used in the Black-Scholes option pricing model to determine the fair value of stock options granted:
		For the Years Ended
		December 31,
		2014		2013
	Dividend yield	0	%	0	%
	Risk free interest rates	0.78 – 1.85	%	0.35 - 1.48	%
	Expected  volatility	59.1 to 67.8	%	63 to 74	%
	Expected term (in years)	3.25 to 5.0		3.5 to 5.0
	The weighted average fair value per share for options granted in 2014 and 2013 was $1.25 and $1.81, respectively.
	There was no dividend declared and paid in 2014.  Though the Company paid a special one-time dividend in 2012, the Company does not expect to pay dividends in the near future therefore it used an expected dividend yield of 0%.  The risk-free interest rate used in the Black-Scholes option pricing model is based on the implied yield at the time of grant available on U.S. Treasury securities with an equivalent term.   Expected volatility is based on the weighted average historical volatility of the Company’s common stock for the equivalent term.  The expected term of options represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience and vesting schedules of similar awards.
	Warrants
	At December 31, 3014, there were no warrants outstanding and at December 31, 2013, there were 1 million warrants to purchase shares of common stock outstanding and exercisable at an exercise price of $1.03 with an expiration date of June 22, 2014.

Commitments_And_Contingencies

Commitments And Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments And Contingencies [Abstract]
Commitments And Contingencies	Note 11:  Commitments and Contingencies
	Royalty Payments
	On January 13, 2014, Global OLED Technology, LLC (“GOT”) filed a complaint against the Company in the New York State Supreme Court sitting in Dutchess County, NY seeking damages for unpaid annual minimum royalties, unpaid royalties on net sales of certain licensed products, unpaid interest, and damages for breach of confidentiality provisions, in each case allegedly arising under a certain license agreement.  GOT also sought a declaratory judgment mandating specific performance of the parties obligations under the license agreement in accordance with the terms and conditions thereof, a full accounting of net sales thereunder and recoupment of reasonable costs and attorneys’ fees.  Following the filing of the complaint, GOT and the Company engaged in discussions in attempts to amicably resolve the dispute between the parties without the costs associated with a lengthy litigation.  The Company recorded a $0.5 million liability on the Company’s Consolidated Balance Sheets as of December 31, 2013 and a selling, general and administrative expense on the Company’s Consolidated Statements of Operations for the year ended December 31, 2013 as a reasonable estimate of the loss contingency related to this matter.
	On April 29, 2014, the Company and GOT entered into a settlement agreement resolving the matter in full.  Pursuant to the settlement agreement, the parties agreed to terminate the patent license agreements entered into in 1998 and 1999, respectively, between FED Corporation (predecessor to the Company) and Eastman Kodak Company (predecessor to GOT), in exchange for mutual releases and the payment by the Company of a one-time settlement amount, substantially all of which was recorded as an expense by the Company as described above. In addition, the parties agreed to dismiss with prejudice the lawsuit commenced by GOT in January 2014.
	Operating Leases
	The Company leases office facilities and office, lab and factory equipment under operating leases.  Certain leases provide for payments of monthly operating expenses. The Company currently has lease commitments for space in Hopewell Junction, New York and Santa Clara, California.
	The Company’s corporate headquarters and manufacturing facilities are leased from IBM in Hopewell Junction, New York.  The Company leases approximately 37,000 square feet to house its equipment for OLED microdisplay fabrication and for research and development, an assembly area and administrative offices. The lease expires in May 2019. The Company leases approximately 1,800 square feet of office space for design and product development in Santa Clara, California and the lease expires in October 2015. In Bellevue, Washington, eMagin leases approximately 1,500 square feet on a month-to-month basis.
	Rent expense was approximately $1.1 million and $1.2 million for years ended December 31, 2014 and 2013, respectively.  The future minimum lease payments for the years 2015 through 2018 are $0.9 million annually and for 2019, $0.4 million.
	Equipment Purchase Commitments
	The Company has committed to equipment purchases of approximately $0.4 million at December 31, 2014.
	Employee benefit plans
	eMagin has a defined contribution plan (the 401(k) Plan) under Section 401(k) of the Internal Revenue Code, which is available to all employees who meet established eligibility requirements. Employee contributions are generally limited to 15% of the employee's compensation. Under the provisions of the 401(k) Plan, eMagin may match a portion of the participating employees' contributions. For the years ended December 31, 2014 and 2013, the matched contributions to the 401(k) Plan were $0.07 million and $0.1 million, respectively.
	Employment agreements
	2014
	On May 13, 2014, the Company and Jerome T. Carollo executed an Amended and Restated Employment Agreement (the “Carollo Employment Agreement”), which amended and restated in its entirety the Executive Employment Agreement, effective as of March 21, 2011.  Pursuant to the Employment Agreement, Mr. Carollo will continue to serve as the Company’s Senior Vice President, Business Development until May 13, 2016. Mr. Carollo is paid a base salary of $292,000 and received stock options valued at $50,000.
	If the Company terminates Mr. Carollo’s employment without Cause, or if Mr. Carollo resigns from his employment for Good Reason, or if Mr. Carollo’s employment is terminated or significantly changed or his salary is decreased as a result of a Change of Control, then Mr. Carollo will be entitled to either the total amount of the base salary that remains unpaid, or monthly salary payments for twelve (12) months, based on his monthly rate of base salary at the date of such termination.  However, in lieu of the aforementioned monthly payments, the Company may in its sole discretion pay such payments in a single lump-sum. Mr. Carollo shall also be entitled to payment for accrued and unused vacation, the immediate vesting of any non-vested equity-related instruments granted under the Employment Agreement, and any bonuses which have accrued prior to the date of termination.  If Mr. Carollo voluntarily resigns from his employment with the Company, other than for Good Reason as defined in the Employment Agreement, or if the Company terminates the his employment for Cause as defined in the Employment Agreement, then Mr. Carollo shall cease to accrue salary, paid time off, employee benefits and other compensation which would have become payable after the date of such resignation or termination, as applicable. See Note 14 – Subsequent Events.
	Effective August 29, 2014, Gabriel G. Matus resigned as Senior Vice President, General Counsel, Secretary and Chief Ethics Officer of the Company and his Employment Agreement was terminated.
	2013
	On December 31, 2013 and effective as of January 1, 2014, the Company and Andrew G. Sculley, Jr. entered into an Amended and Restated Employment Agreement (the “Sculley Employment Agreement”), which amended and restated in its entirety the Executive Employment Agreement, dated as of June 1, 2011.  Pursuant to the Sculley Employment Agreement, Mr. Sculley will continue serving as the Company’s President and Chief Executive Officer until June 30, 2016 unless it is terminated sooner pursuant to its terms. Under the Sculley Employment Agreement, Mr. Sculley is paid an annual salary of $410,000.  Mr. Sculley may receive equity-related instruments on an annual basis in amounts and subject to vesting and other terms and conditions as the Board of Directors or Compensation Committee of the Board of Directors may determine. During the term of the Sculley Employment Agreement, the Company shall use its reasonable good faith efforts to cause Mr. Sculley to be elected to the Company’s Board of Directors.
	Pursuant to the Sculley Employment Agreement, Mr. Sculley’s employment may be terminated by the Company with or without Cause (as defined in the Sculley Employment Agreement) and he may terminate his employment for Good Reason (as defined in the Sculley Employment Agreement), among other reasons.  If Mr. Sculley’s employment is terminated without Cause or if he terminates it for Good Reason, then Mr. Sculley shall, at the Company’s sole discretion, be entitled to the lesser of (i) the total amount of his base salary that remains unpaid under the Sculley Employment Agreement, which shall be paid monthly, or (ii) monthly salary payments for twelve (12) months, based on Mr. Sculley’s monthly rate of base salary at the date of such termination, which the Company may pay in a lump-sum in lieu of the aforementioned monthly payments. The payment of the severance is contingent upon Mr. Sculley executing a release agreement, such release becoming effective, and only so long as Mr. Sculley does not revoke or breach the provision of the release or the restrictive covenants set forth in Sections 4 and 5 of the Sculley Employment Agreement.  Mr. Sculley shall also be entitled to (i) payment for accrued and unused vacation; (ii) the immediate vesting of any non-vested equity-related instruments granted pursuant to Section 2.6 of the Sculley Employment Agreement; and (iii) any bonuses which have accrued prior to the date of Mr. Sculley’s termination.  If the Sculley Employment Agreement is terminated with Cause or if Mr. Sculley terminates it without Good Reason then Mr. Sculley shall cease to accrue salary, personal time off, benefits and other compensation on the date of such termination.
	On December 31, 2013 and effective as of January 1, 2014, the Company and Paul C. Campbell entered into an Amended and Restated Employment Agreement (the “Campbell Employment Agreement”), which amended and restated in its entirety the Executive Employment Agreement, dated as of May 8, 2012. Pursuant to the Campbell Employment Agreement, Mr. Campbell will continue serving as the Company’s Chief Financial Officer and Treasurer until December 31, 2015 unless it is terminated sooner pursuant to its terms. Under the Campbell Employment Agreement, Mr. Campbell is paid an annual salary of $335,000.  Mr. Campbell may receive equity-related instruments on an annual basis in amounts and subject to vesting and other terms and conditions as the Board of Directors or Compensation Committee of the Board of Directors may determine.
	Pursuant to the Campbell Employment Agreement, Mr. Campbell’s employment may be terminated by the Company with or without Cause (as defined in the Campbell Employment Agreement) and he may terminate his employment for Good Reason (as defined in the Campbell Employment Agreement), among other reasons.  If Mr. Campbell’s employment is terminated without Cause or if he terminates it for Good Reason, then Mr. Campbell shall, at the Company’s sole discretion, be entitled to the lesser of (i) the total amount of his base salary that remains unpaid under the Campbell Employment Agreement, which shall be paid monthly, or (ii) monthly salary payments for twelve (12) months, based on Mr. Campbell’s monthly rate of base salary at the date of such termination, which the Company may pay in a lump-sum in lieu of the aforementioned monthly payments. The payment of the severance is contingent upon Mr. Campbell executing a release agreement, such release becoming effective, and only so long as Mr. Campbell does not revoke or breach the provision of the release or the restrictive covenants set forth in Sections 4 and 5 of the Campbell Employment Agreement.  Mr. Campbell shall also be entitled to (i) payment for accrued and unused vacation; (ii) the immediate vesting of any non-vested equity-related instruments granted pursuant to Section 2.6 of the Campbell Employment Agreement; and (iii) any bonuses which have accrued prior to the date of Mr. Campbell’s termination.  If the Campbell Employment Agreement is terminated with Cause or if Mr. Campbell terminates it without Good Reason then Mr. Campbell shall cease to accrue salary, personal time off, benefits and other compensation on the date of such termination.  Pursuant to the Campbell Employment Agreement, the Company paid for certain relocation related expenses up to a maximum of $10,000.
	The Company and Gabriel G. Matus entered into an employment agreement, dated as of April 30, 2013 (the “Matus Employment Agreement”), pursuant to which Mr. Matus will serve as the Company’s Senior Vice President, General Counsel and Secretary.  Mr. Matus’ employment with the Company commenced on May 13, 2013 (the “Commencement Date”) and shall continue until May 13, 2015, unless terminated sooner pursuant to the Matus Employment Agreement.  Pursuant to the Matus Employment Agreement, Mr. Matus is paid a base salary of $234,000 per annum and received stock options valued at $50,000.
	If Mr. Matus voluntarily terminates his employment with the Company, other than for Good Reason (as such term is defined in the Employment Agreement), he shall cease to accrue salary, personal time off, benefits and other compensation on the date of voluntary termination and all unvested stock options granted to Mr. Matus will be void. The Company may terminate Mr. Matus’ employment with or without cause.  If the Company terminates Mr. Matus’ employment without Cause (as such term is defined in the Employment Agreement) after 120 days from the date of the Employment Agreement, Mr. Matus will be entitled to monthly salary payments for twelve (12) months, based on his monthly rate of base salary at the date of such termination, provided, however, in lieu of the aforementioned monthly payments the Company may in its sole discretion pay such amounts in a single lump-sum payment.  In addition, any non-vested options pursuant to the Employment Agreement shall vest immediately. Mr. Matus shall also be entitled to receive (i) payment for accrued and unpaid vacation pay, and (ii) all bonuses that have accrued during the term of the Employment Agreement but have not been paid.
	Future sales concessions
	In the first quarter of 2014, the Company received a notification to stop shipments to three of its customers regarding a possible wire bonding problem in some of the microdisplays shipped to these customers. Shipments to two of the three customers resumed in 2014.   As the third customer (“this Customer”) was not interested in continuing to use eMagin’s standard commercial microdisplay which was originally shipped, eMagin has been working, at this Customer’s request, on a more mechanically robust display configuration.  This Customer provided a proposal to eMagin which the Company countered with a proposal that provided concessions to this Customer predicated on future business.  To date, there is no executed agreement.  However, it is more likely than not that ultimately there will be a final proposal with acceptance of some concessions.  It is reasonably possible that eMagin will incur a future loss once the terms of the proposal are finalized; however, given the uncertainty that still exists, the amount of the potential future loss cannot be reasonably estimated at this time.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2014
Concentrations [Abstract]
Concentrations	Note 12:  Concentrations
	The following is a schedule of revenue by geographic location (in thousands):
		For the Years Ended
		December 31,
		2014			2013
	North and South America	$	13,560		$	17,674
	Europe, Middle East, and Africa		9,246			7,632
	Asia Pacific		2,909			2,684
	Total	$	25,715		$	27,990
		For the Years Ended
		December 31,
		2014			2013
	Domestic		51	%		62	%
	International		49	%		38	%
	The Company purchases principally all of its silicon wafers from a single supplier located in Taiwan.
	In 2014, there was no customer that accounted for 10% of its revenue. In 2013, there were 2 customers that accounted for 22% of its revenue and 17% of its accounts receivable.
	At December 31, 2014 and 2013, there were 10 customers who comprised 78% and 70%, respectively, of the outstanding accounts receivable. In 2014, the Company had 3 customers that together accounted for 44% of its outstanding receivable and in 2013, 2 customers that together 26% of its outstanding receivable.

Quarterly_Financial_Informatio

Quarterly Financial Information	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information [Abstract]
Quarterly Financial Information	Note 13 – QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
	Summarized quarterly financial information for 2014 and 2013 are as follows (in thousands except share data):
		Quarters Ended
			March 31,		June 30,		September 30,		December 31,
			2014		2014		2014		2014
	Revenues	$	6,278	$	7,018	$	5,699	$	6,720
	Gross profit	$	1,931	$	2,169	$	1,745	$	1,539
	Net loss before income tax	$	-1,618	$	-1,047	$	-1,036	$	-1,556
	Net loss	$	-1,618	$	-1,047	$	-1,036	$	-1,556
	Net loss per share - basic	$	-0.07	$	-0.04	$	-0.04	$	-0.07
	Net loss per share - diluted	$	-0.07	$	-0.04	$	-0.04	$	-0.07
	Weighted average number of shares outstanding - basic		23,778,110		23,940,800		24,842,945		24,943,181
	Weighted average number of shares outstanding - diluted		23,778,110		23,940,800		24,842,945		24,943,181
		Quarters Ended
			March 31,		June 30,		September 30,		December 31,
			2013		2013		2013		2013
	Revenues	$	8,503	$	7,028	$	6,329	$	6,130
	Gross profit	$	3,751	$	2,391	$	2,225	$	59
	Net (loss) income before income tax	$	325	$	-1,128	$	-1,057	$	-3,323
	Net (loss) income	$	205	$	-1,008	$	-4,559	$	-8,705
	Net (loss) income per share - basic	$	0.01	$	-0.04	$	-0.19	$	-0.37
	Net (loss) income per share - diluted	$	0.01	$	-0.04	$	-0.19	$	-0.37
	Weighted average number of shares outstanding - basic		23,527,072		23,586,413		23,718,106		23,726,626
	Weighted average number of shares outstanding - diluted		25,332,976		23,586,413		23,718,106		23,726,626

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events
	Note 14 – SUBSEQUENT EVENTS
	Effective January 16, 2015, Jerome T. Carollo resigned as Senior Vice President of Business Development and his Employment Agreement was terminated.

Signicant_Accounting_Policies_

Signicant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies [Abstract]
Principles Of Consolidation	Principles of consolidation
	The accompanying consolidated financial statements include the accounts of eMagin Corporation and its wholly owned subsidiary.  All intercompany transactions have been eliminated in consolidation.
Use Of Estimates	Use of estimates
	In accordance with accounting principles generally accepted in the United States of America, management utilizes certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments related to, among others, allowance for doubtful accounts, warranty reserves, inventory reserves, stock-based compensation expense, deferred tax asset valuation allowances, fair value of financial instruments, litigation and other loss contingencies. Management bases its estimates and judgments on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.
Revenue And Cost Recognition	Revenue and cost recognition
	Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, selling price is fixed or determinable and collection is reasonably assured.   Product revenue is generally recognized when products are shipped to customers.
	The Company also earns revenues from certain research and development (“R&D”) activities (contract revenues) under both firm fixed-price contracts and cost-type contracts.  Revenues relating to firm fixed-price contracts and cost-type contracts are generally recognized on the percentage-of-completion method of accounting as costs are incurred (cost-to-cost basis).  Progress is generally based on a cost-to-cost approach however an alternative method may be used such as physical progress, labor hours or others depending on the type of contract.   Physical progress is determined as a combination of input and output measures as deemed appropriate by the circumstances.  Contract costs include all direct material and labor costs and an allocation of allowable indirect costs as defined by each contract, as periodically adjusted to reflect revised agreed upon rates. These rates are subject to audit by the other party.
Product Warranty	Product warranty
	The Company offers a one-year product replacement warranty. In general, the standard policy is to repair or replace the defective products. The Company accrues for estimated returns of defective products at the time revenue is recognized based on historical activity as well as for specific known product issues. The determination of these accruals requires the Company to make estimates of the frequency and extent of warranty activity and estimate future costs to replace the products under warranty. If the actual warranty activity and/or repair and replacement costs differ significantly from these estimates, adjustments to cost of revenue may be required in future periods.
	The following table provides a summary of the activity related to the Company's warranty liability, included in other current liabilities, during the years ended December 31, 2014 and 2013 (in thousands):
		For the Year Ended
		December 31,
		2014			2013
	Beginning balance	$	394		$	276
	Warranty accruals		760			425
	Warranty usage		-491			-307
	Ending balance	$	663		$	394
Research And Development Expenses	Research and development expenses
	Research and development costs are expensed as incurred.
Cash And Cash equivalents	Cash and cash equivalents
	All highly liquid instruments with an original maturity of three months or less at the date of purchase are considered to be cash equivalents.
Investments	Investments
	Investments consist of FDIC-insured certificates of deposit which the Company classifies as held-to-maturity since it has the positive intent and ability to hold them until maturity and the investments are carried at amortized cost.  As of December 31, 2014 and 2013, the held-to-maturity investments were $0.75 million and $7 million, respectively, maturing within 6 months and 18 months, respectively.
Accounts Receivable	Accounts receivable
	The majority of the Company’s commercial accounts receivable are due from Original Equipment Manufacturers ("OEM’s”). Credit is extended based on an evaluation of a customer’s financial condition and, generally, collateral is not required. Accounts receivable are payable in U.S. dollars, are due within 30-90 days and are stated at amounts due from customers net of an allowance for doubtful accounts. Any account outstanding longer than the contractual payment terms is considered past due.
Allowance For Doubtful Accounts	Allowance for doubtful accounts
	The allowance for doubtful accounts reflects an estimate of probable losses inherent in the accounts receivable balance. The allowance is determined based on a variety of factors, including the length of time receivables are past due, historical experience, the customer's current ability to pay its obligation, and the condition of the general economy and the industry as a whole.  The Company will record a specific reserve for individual accounts when the Company becomes aware of a customer's inability to meet its financial obligations, deterioration in the customer's operating results or financial position, or deterioration in the customer’s credit history. If circumstances related to customers change, the Company would further adjust estimates of the recoverability of receivables.  Account balances, when determined to be uncollectible, are charged against the allowance.
Inventory	Inventory
	Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out method. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. The Company regularly reviews inventory quantities on hand, future purchase commitments with the Company’s suppliers, and the estimated utility of the inventory. If the Company review indicates a reduction in utility below carrying value, the inventory is reduced to a new cost basis.
Equipment, Furniture And Leasehold Improvements	Equipment, furniture and leasehold improvements
	Equipment, furniture and leasehold improvements are stated at cost. Depreciation on equipment is calculated using the straight-line method of depreciation over its estimated useful life. Amortization of leasehold improvements is calculated by using the straight-line method over the shorter of their estimated useful lives or lease terms. Expenditures for maintenance and repairs are charged to expense as incurred.
	The Company performs impairment tests on its long-lived assets when circumstances indicate that their carrying amounts may not be recoverable. If required, recoverability is tested by comparing the estimated future undiscounted cash flows of the asset or asset group to its carrying value. Impairment losses, if any, are recognized based on the excess of the assets' carrying amounts over their estimated fair values.
Intangible Assets	Intangible assets
	The Company’s intangible assets are patents that are recorded at purchase price as of the date acquired and amortized over the expected useful life which is generally the remaining life of the patent.  During 2014, the Company purchased several patents for $290 thousand which will be amortized over their remaining useful life.  The net book value of all intangible assets was $301 thousand at December 31, 2014.  The accumulated amortization as of December 31, 2014 was $54 thousand.  As of December 31, 2014, the weighted average remaining useful life of the patents was approximately 6.9 years.
	Total intangible amortization expense was approximately $16 thousand and $4 thousand for each of the years ended December 31, 2014 and 2013, respectively.   Estimated amortization expense for the next five years, beginning with 2015, is as follows:  $58 thousand, $54 thousand, $54 thousand, $54 thousand, $32 thousand and thereafter, $49 thousand.
Advertising	Advertising
	Costs related to advertising and promotion of products are charged to sales and marketing expense as incurred.  There was no  advertising expense for the years ended December 31, 2014 and 2013.
Shipping And Handling Fees	Shipping and handling fees
	The Company includes costs related to shipping and handling in cost of goods sold.
Income Taxes	Income taxes
	The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.  The effect on deferred tax assets and liabilities of changes in tax rates will be recognized as income or expense in the period that the change occurs.  A valuation allowance for deferred tax assets is recorded when it is more likely than not that some or all of the benefit from the deferred tax asset will not be realized.  Changes in circumstances, assumptions and clarification of uncertain tax regimes may require changes to any valuation allowances associated with the Company’s deferred tax assets.
	Due to the Company’s operating loss carryforwards, all tax years remain open to examination by the major taxing jurisdictions to which the Company is subject. In the event that the Company is assessed interest or penalties at some point in the future, it will be classified in the financial statements as tax expense.
Income (Loss) Per Common Share	Income (loss) per common share
	Basic income (loss) per share (“Basic EPS”) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period.  Diluted income (loss) per share (“Diluted EPS”) is computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the reporting period while also giving effect to all potentially dilutive common shares that were outstanding during the reporting period.
	In accordance with ASC 260, entities that have issued securities other than common stock that participate in dividends with the common stock (“participating securities”) are required to apply the two-class method to compute basic EPS.  The two-class method is an earnings allocation method under which EPS is calculated for each class of common stock and participating security as if all such earnings had been distributed during the period.  On December 22, 2008, the Company issued Convertible Preferred Stock – Series B which participates in dividends with the Company’s common stock and is therefore considered to be a participating security. The participating convertible preferred stock is not required to absorb any net loss.  The Company uses the more dilutive method of calculating the diluted earnings per share, either the two class method or “if-converted” method.  Under the “if-converted” method, the convertible preferred stock is assumed to have been converted into common shares at the beginning of the period.
	For the years ended December 31, 2014 and 2013, the Company reported a net loss and as a result, basic and diluted loss per common share are the same. Therefore, in calculating net loss per share amounts, shares underlying the potentially dilutive common stock equivalents were excluded from the calculation of diluted net income per common share because their effect was anti-dilutive.
	The following is a table of the potentially dilutive common stock equivalents for the years ended December 31, 2014 and 2013 that were not included in diluted EPS as their effect would be anti-dilutive:
		For the Years Ended December 31,
		2014		2013
	Options	4,510,107		4,597,186
	Warrants	—		1,000,000
	Convertible preferred stock	7,545,333		7,545,333
	Total potentially dilutive common stock equivalents	12,055,440		13,142,519
Comprehensive Income	Comprehensive income (loss)
	Comprehensive income (loss) refers to net income (loss) and other revenue, expenses, gains and losses that, under generally accepted accounting principles, are recorded as an element of shareholders’ equity but are excluded from the calculation of net income (loss).
	The Company's operations did not give rise to any material items includable in comprehensive income (loss), which were not already in net income (loss) for the years ended December 31, 2014 and 2013. Accordingly, the Company's comprehensive income (loss) is the same as its net income (loss) for the periods presented.
Stock-Based Compensation	Stock-based compensation
	The Company uses the fair value method of accounting for share-based compensation arrangements. The fair values of stock options are estimated at the date of grant using the Black-Scholes option valuation model. Stock-based compensation expense is reduced for estimated forfeitures and is amortized over the vesting period using the straight-line method.
Concentration Of Credit Risk	Concentration of credit risk
	The majority of eMagin’s products are sold throughout North America, Asia, and Europe.  Sales to the Company’s recurring customers are generally made on open account while sales to occasional customers are typically made on a prepaid basis.  eMagin performs periodic credit evaluations on its recurring customers and generally does not require collateral.  An allowance for doubtful accounts is maintained for credit losses.
	Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents and short-term and long-term investments.  The Company’s cash and cash equivalents are deposited with financial institutions which, at times, may exceed federally insured limits.  The Company has funds invested in a money market account which are not insured.  The Company has Certificates of Deposits (“CDs”) classified as short and long-term investments, which are federally insured. To date, the Company has not experienced any loss associated with this risk.
Recently Issued Accounting Standards	Recently issued accounting standards
	In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled when products are transferred to customers. ASU 2014-09 will be effective for the Company beginning January 1, 2017. Early adoption is not permitted. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. The Company is currently evaluating the impact of adopting the new revenue standard on its consolidated financial statements.

Significant_Accounting_Policie1

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Significant Accounting Policies [Abstract]
Summary Of Activity Related To Warranty Liability Included In Other Current Liabilities
		For the Year Ended
		December 31,
		2014			2013
	Beginning balance	$	394		$	276
	Warranty accruals		760			425
	Warranty usage		-491			-307
	Ending balance	$	663		$	394
Potentially Dilutive Common Stock Equivalents
		For the Years Ended December 31,
		2014		2013
	Options	4,510,107		4,597,186
	Warrants	—		1,000,000
	Convertible preferred stock	7,545,333		7,545,333
	Total potentially dilutive common stock equivalents	12,055,440		13,142,519

Accounts_Receivables_Net_Table

Accounts Receivables, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Accounts Receivables, Net [Abstract]
Schedule Of Accounts Receivable
		December 31,
		2014		2013
	Accounts receivable	$	4,717	$	4,464
	Less allowance for doubtful accounts		-673		-145
	Accounts receivable, net	$	4,044	$	4,319

Inventories_Net_Tables

Inventories, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Inventories, Net [Abstract]
Schedule Of Components of Inventories
		December 31,
		2014		2013
	Raw materials	$	2,506	$	1,905
	Work in process		1,086		987
	Finished goods		1,291		637
	Total inventories		4,883		3,529
	Less inventory reserve		-297		-95
	Total inventories, net	$	4,586	$	3,434

Prepaid_Expenses_And_Other_Cur1

Prepaid Expenses And Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Prepaid Expense And Other Current Assets [Abstract]
Prepaid Expenses And Other Current Assets
		December 31,
		2014		2013
	Vendor prepayments	$	152	$	52
	Other prepaid expenses*		504		693
	Total prepaid expenses and other current assets	$	656	$	745
	*No individual amounts greater than 5% of current assets.

Equipment_Furniture_And_Leaseh1

Equipment, Furniture And Leasehold Improvements (Tables)	12 Months Ended
	Dec. 31, 2014
Equipment, Furniture And Leasehold Improvements [Abstract]
Equipment, Furniture And Leasehold Improvements
		December 31,
		2014		2013
	Computer hardware and software	$	1,410	$	1,391
	Lab and factory equipment		13,084		10,760
	Furniture, fixtures and office equipment		344		329
	Assets under capital leases		66		66
	Construction in progress		1,905		2,801
	Leasehold improvements		473		473
	Total equipment, furniture and leasehold improvements		17,282		15,820
	Less:  accumulated depreciation		-7,865		-6,701
	Equipment, furniture and leasehold improvements, net	$	9,417	$	9,119

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Schedule Of Income Before Income Tax
		For the Years Ended
		December 31,
		2014			2013
	Domestic	$	-5,257		$	-5,183
	Total	$	-5,257		$	-5,183
Schedule Of Federal And State Income Tax (Benefit) Provision
		For the Years Ended
		December 31,
		2014			2013
	Current:	$			$
	Federal		-			1
	State		-			2
	Total current tax expense		-			3
	Deferred:
	Federal		-			8,803
	State		-			78
	Total deferred tax expense		-			8,881
	Total tax expense	$	-		$	8,884
Deferred Tax Assets And Liabilities
		For the Years Ended
		December 31,
		2014			2013
	Deferred tax assets:
	Federal and state net operating loss carryforwards	$	37,635		$	36,284
	Research and development tax credit carryforwards		2,214			1,979
	Stock based compensation		3,922			3,665
	Other provision and expenses not currently deductible		1,093			755
	Total deferred tax assets		44,864			42,683
	Deferred tax liabilities:
	Depreciation and amortization		-682			-374
	Prepaid expenses		-145			-191
	Total deferred liabilities		-827			-565
	Less valuation allowance		-44,037			-42,118
	Net deferred tax asset	$	—		$	—
Federal Net Operating Losses And Tax Credit Carryforwards
			Net			Research and
			Operating			Development
			Losses			Tax Credits
		(in millions)
	2018-2021	$	44.6		$	0.8
	2022-2025		42.8			—
	2026-2034		26.7			1.4
		$	114.1		$	2.2
Reconciliation Of Effective Tax Rate
		For the Years Ended
		December 31,
		2014			2013
	U.S. Federal income tax expense at federal statutory rate		34	%		34	%
	Change in valuation allowance		-37			-214
	Change in effective state tax rate		-2			1
	Credits		5			8
	Effective tax rate		—	%		-171	%

Stock_Compensation_Tables

Stock Compensation (Tables)	12 Months Ended
	Dec. 31, 2014
Stock Compensation [Abstract]
Stock Option Activity
		Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
	Outstanding at December 31, 2013		4,597,186		$	3.82
	Options granted		404,113			2.63
	Options exercised		-266,488			1.03
	Options forfeited		-109,055			3.89
	Options cancelled or expired		-115,649			5.84
	Outstanding at December 31, 2014		4,510,107		$	3.83		3.93	$	1,292,171
	Vested or expected to vest at December 31, 2014 (1)		4,493,527		$	3.83		3.93	$	1,291,519
	Exercisable at December 31, 2014		4,095,661		$	3.87		3.89	$	1,246,530
	(1) The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.
Allocation Of Stock-Based Compensation To Expense Catagories
		For the Years Ended
		December 31,
		2014			2013
	Cost of revenue	$	154		$	285
	Research and development		262			566
	Selling, general and administrative		609			1,231
	Total stock compensation expense	$	1,025		$	2,082
Key Assumptions Used For Black-Scholes Option Pricing Model
		For the Years Ended
		December 31,
		2014		2013
	Dividend yield	0	%	0	%
	Risk free interest rates	0.78 – 1.85	%	0.35 - 1.48	%
	Expected  volatility	59.1 to 67.8	%	63 to 74	%
	Expected term (in years)	3.25 to 5.0		3.5 to 5.0

Concentrations_Tables

Concentrations (Tables)	12 Months Ended
	Dec. 31, 2014
Concentrations [Abstract]
Schedule Of Revenue By Geographic Location
		For the Years Ended
		December 31,
		2014			2013
	North and South America	$	13,560		$	17,674
	Europe, Middle East, and Africa		9,246			7,632
	Asia Pacific		2,909			2,684
	Total	$	25,715		$	27,990
		For the Years Ended
		December 31,
		2014			2013
	Domestic		51	%		62	%
	International		49	%		38	%

Quarterly_Financial_Informatio1

Quarterly Financial Information (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information [Abstract]
Schedule Of Quarterly Financial Information
		Quarters Ended
			March 31,		June 30,		September 30,		December 31,
			2014		2014		2014		2014
	Revenues	$	6,278	$	7,018	$	5,699	$	6,720
	Gross profit	$	1,931	$	2,169	$	1,745	$	1,539
	Net loss before income tax	$	-1,618	$	-1,047	$	-1,036	$	-1,556
	Net loss	$	-1,618	$	-1,047	$	-1,036	$	-1,556
	Net loss per share - basic	$	-0.07	$	-0.04	$	-0.04	$	-0.07
	Net loss per share - diluted	$	-0.07	$	-0.04	$	-0.04	$	-0.07
	Weighted average number of shares outstanding - basic		23,778,110		23,940,800		24,842,945		24,943,181
	Weighted average number of shares outstanding - diluted		23,778,110		23,940,800		24,842,945		24,943,181
		Quarters Ended
			March 31,		June 30,		September 30,		December 31,
			2013		2013		2013		2013
	Revenues	$	8,503	$	7,028	$	6,329	$	6,130
	Gross profit	$	3,751	$	2,391	$	2,225	$	59
	Net (loss) income before income tax	$	325	$	-1,128	$	-1,057	$	-3,323
	Net (loss) income	$	205	$	-1,008	$	-4,559	$	-8,705
	Net (loss) income per share - basic	$	0.01	$	-0.04	$	-0.19	$	-0.37
	Net (loss) income per share - diluted	$	0.01	$	-0.04	$	-0.19	$	-0.37
	Weighted average number of shares outstanding - basic		23,527,072		23,586,413		23,718,106		23,726,626
	Weighted average number of shares outstanding - diluted		25,332,976		23,586,413		23,718,106		23,726,626

Significant_Accounting_Policie2

Significant Accounting Policies (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Significant Accounting Policies [Line Items]
Standard product warranty period	1 year
Held-to-maturity investments	$750,000	$7,000,000
Aquired patents	290,000
Aquired patents, weighted average remaining useful life	6 years 10 months 24 days
Net book value of all intangible assets	301,000
Acquired patents, accumulated amortization	54,000
Acquired patents, amortization expense	16,000	4,000
Acquired patents, estimated amortization expense, 2015	58,000
Acquired patents, estimated amortization expense, 2016	54,000
Acquired patents, estimated amortization expense, 2017	54,000
Acquired patents, estimated amortization expense, 2018	54,000
Acquired patents, estimated amortization expense, 2019	32,000
Advertising expense	$0	$0
Minimum [Member]
Significant Accounting Policies [Line Items]
Investments maturity period	6 months
Accounts receivable, balance due	30 days
Maximum [Member]
Significant Accounting Policies [Line Items]
Investments maturity period		18 months
Accounts receivable, balance due	90 days

Significant_Accounting_Policie3

Significant Accounting Policies (Summary Of Activity Related To Warranty Liability Included In Other Current Liabilities) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Significant Accounting Policies [Abstract]
Beginning balance	$394	$276
Warranty accruals	760	425
Warranty usage	-491	-307
Ending balance	$663	$394

Significant_Accounting_Policie4

Significant Accounting Policies (Potentially Dilutive Common Stock Equivalents) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common stock equivalents	12,055,440	13,142,519
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common stock equivalents	4,510,107	4,597,186
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common stock equivalents		1,000,000
Series B Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive common stock equivalents	7,545,333	7,545,333

Accounts_Receivables_Net_Detai

Accounts Receivables, Net (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounts Receivables, Net [Abstract]
Accounts receivable	$4,717	$4,464
Less allowance for doubtful accounts	-673	-145
Accounts receivable, net	$4,044	$4,319

Inventories_Net_Details

Inventories, Net (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventories, Net [Abstract]
Raw materials	$2,506	$1,905
Work in process	1,086	987
Finished goods	1,291	637
Total inventories	4,883	3,529
Less inventory reserve	-297	-95
Total inventories, net	$4,586	$3,434

Prepaid_Expenses_And_Other_Cur2

Prepaid Expenses And Other Current Assets (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Prepaid Expense And Other Current Assets [Abstract]
Vendor prepayments	$152		$52
Other prepaid expenses	504	[1]	693	[1]
Total prepaid expenses and other current assets	$656		$745
Maximum percentage of other prepaid expenses to currents assets	5.00%
[1]	No individual amounts greater than 5% of current assets.

Equipment_Furniture_And_Leaseh2

Equipment, Furniture And Leasehold Improvements (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	$17,282	$15,820
Less: accumulated depreciation	-7,865	-6,701
Equipment, furniture and leasehold improvements, net	9,417	9,119
Depreciation expense	1,200	900
Computer Hardware And Software [Member]
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	1,410	1,391
Lab And Factory Equipment [Member]
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	13,084	10,760
Furniture, Fixtures And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	344	329
Assets Under Capital Leases [Member]
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	66	66
Construction In Progress [Member]
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	1,905	2,801
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total equipment, furniture and leasehold improvements	$473	$473

Debt_Details

Debt (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Debt [Abstract]
Interest paid, capitalized or accrued	$42,000	$42,000
Line of credit facility, borrowing capacity, description	the Company may borrow up to a maximum of $3 million based on a borrowing base equivalent of 75% of eligible accounts receivable.
Line of credit facility, maximum borrowing capacity	3,000,000
Eligible accounts receivable percentage	75.00%
Monthly interest payment required	1,000
Interest rate plus Prime	4.00%
Minimum interest rate	7.25%
Early termination fee	6,000
Renewal date for credit facility	1-Sep-15
Amortizable loan fees	30,000	30,000
Outstanding amount on credit facility	$0

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Abstract]
Net deferred tax assets	$44,000,000	$42,100,000
Income tax expense		8,884,000
Contributed capital adjustment if future tax benefits are subsequently recognized	1,300,000
Federal net operating loss carryforwards	114,100,000
State net operating loss carryforwards	1,200,000
Research and development tax credit carryforwards	$2,214,000	$1,979,000

Income_Taxes_Schedule_Of_Incom

Income Taxes (Schedule Of Income Before Income Tax) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Abstract]
Domestic									($5,257)	($5,183)
Loss before provision for income taxes	($1,556)	($1,036)	($1,047)	($1,618)	($3,323)	($1,057)	($1,128)	$325	($5,257)	($5,183)

Income_Taxes_Schedule_Of_Feder

Income Taxes (Schedule Of Federal And State Income Tax (Benefit) Provision) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Income Taxes [Abstract]
Federal	$1
State	2
Total current tax expense	3
Federal	8,803
State	78
Total deferred tax expense (benefit)	8,881
Provision for income taxes	$8,884

Income_Taxes_Deferred_Tax_Asse

Income Taxes (Deferred Tax Assets And Liabilities) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Income Taxes [Abstract]
Federal and state net operating loss carryforwards	$37,635	$36,284
Research and development tax credit carryforwards	2,214	1,979
Stock based compensation	3,922	3,665
Other provisions and expenses not currently deductible	1,093	755
Total deferred tax assets	44,864	42,683
Depreciation and amortization	-682	-374
Prepaid expenses	-145	-191
Total deferred liabilities	-827	-565
Less valuation allowance	-44,037	-42,118
Net deferred tax asset

Income_Taxes_Federal_Net_Opera

Income Taxes (Federal Net Operating Losses And Tax Credit Carryforwards) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Operating Loss Carryforwards [Line Items]
Net Operating Losses	$114,100,000
Research and Development Tax Credits	2,214,000	1,979,000
2018-2021 [Member
Operating Loss Carryforwards [Line Items]
Net Operating Losses	44,600,000
Research and Development Tax Credits	800,000
2022-2025 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Losses	42,800,000
2026-2034 [Member]
Operating Loss Carryforwards [Line Items]
Net Operating Losses	26,700,000
Research and Development Tax Credits	$1,400,000

Income_Taxes_Reconciliation_Of

Income Taxes (Reconciliation Of Effective Tax Rate) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]
U.S. Federal income tax expense at federal statutory rate	34.00%	34.00%
Change in valuation allowance	-37.00%	-214.00%
Change in effective state tax rate	-2.00%	1.00%
Credits	5.00%	8.00%
Effective tax rate		-171.00%

Shareholders_Equity_Details

Shareholders' Equity (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Shareholders' Equity [Line Items]
Proceeds from stock options exercised	$275,000	$394,000
Exercise of common stock options, shares	266,488	254,078
Proceeds from exercise of stock warrants	1,000,000
Number of warrants exercised	1,000,000	0
Warrants outstanding		1,000,000
Shares repurchased	0	12,066
Average cost of shares purchased		$2.99
Remaining authorized purchase amount	$2,000,000
Series B Convertible Preferred Stock [Member]
Shareholders' Equity [Line Items]
Preferred stock, shares issued	5,659	5,659
Preferred stock, shares outstanding	5,659	5,659

Stock_Compensation_Narrative_D

Stock Compensation (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013	Nov. 05, 2008	Nov. 03, 2011	17-May-13
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted, shares	404,113
Ratable vesting period	3 years 11 months 5 days	[1]
Options in-the-money	1,337,104
Closing stock price	$2.32
Expected dividend yield	0.00%
Intrinsic value of options exercised	$400,000
Excess tax benefit	200,000
Unrecognized stock option compensation net of for feitures	$400,000
Unrecognized compensation cost, weighted average period of recognition	1 year 3 months 18 days
Weighted average fair value per share for options granted	$1.25		$1.81
Dividend yield	0.00%		0.00%
Warrant shares			1,000,000
Warrants exercise price per share			$1.03
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ratable vesting period	5 years
The 2005 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant	300,000
Employee purchase price, percentage of fair market value	85.00%
The 2008 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized				2,000,000
Options granted, shares	0
The 2011 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized					1,400,000
Options granted, shares	0
The 2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized						1,500,000
Options granted, shares	404,113
The 2011, 2008 and 2003 Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant	1,369,464
[1]	The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.

Stock_Compensation_Stock_Optio

Stock Compensation (Stock Option Activity) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Stock Compensation [Abstract]
Outstanding, shares	4,597,186
Options granted, shares	404,113
Options exercised, shares	-266,488		-254,078
Options forfeited, shares	-109,055
Options cancelled or expired, shares	-115,649
Outstanding, shares	4,510,107		4,597,186
Vested or expected to vest, shares	4,493,527	[1]
Exercisable, shares	4,095,661
Outstanding, exercise price	$3.82
Options granted, exercise price	$2.63
Options exercised, exercise price	$1.03
Options forfeited, exercise price	$3.89
Options cancelled or expired, exercise price	$5.84
Outstanding, exercise price	$3.83		$3.82
Vested or expected to vest, exercise price	$3.83	[1]
Exercisable, exercise price	$3.87
Outstanding, contractual life	3 years 11 months 5 days
Vested or expected to vest, contractual life	3 years 11 months 5 days	[1]
Exercisable, contractual life	3 years 10 months 21 days
Outstanding, intrinsic value	$1,292,171
Vested or expected to vest, intrinsic value	1,291,519	[1]
Exercisable, intrinsic value	$1,246,530
[1]	The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.

Stock_Compensation_Allocation_

Stock Compensation (Allocation Of Stock-Based Compensation To Expense Catagories) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock compensation expense	$1,025	$2,082
Cost of Sales [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock compensation expense	154	285
Research and Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock compensation expense	262	566
Selling, General and Administrative Expenses [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock compensation expense	$609	$1,231

Stock_Compensation_Key_Assumpt

Stock Compensation (Key Assumptions Used For Black-Scholes Option Pricing Model) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%	0.00%
Risk free interest rates, minimum	0.78%	0.35%
Risk free interest rates, maximum	1.85%	1.48%
Expected volatility, minimum	59.10%	63.00%
Expected volatility, maximum	67.80%	74.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	3 years 3 months	3 years 6 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years	5 years

Commitments_And_Contingencies_

Commitments And Contingencies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Commitments And Contingencies [Line Items]
Loss contingency liability		$500,000
Rent expense	1,100,000	1,200,000
Future minimum lease payments due in 2015	900,000
Future minimum lease payments due in 2016	900,000
Future minimum lease payments due in 2017	900,000
Future minimum lease payments due in 2018	900,000
Future minimum lease payments due in 2019	400,000
Contribution limitation to percentage of compensation	15.00%
Employer contributions	70,000	100,000
Equipment purchases commitments	400,000
Stock options, value	400,000
Salary payment entitlement threshold, number of days	120 days
Senior Vice President, Business Development [Member]
Commitments And Contingencies [Line Items]
Stock options, value	50,000
Senior Vice President, General Counsel and Secretary [Member]
Commitments And Contingencies [Line Items]
Stock options, value	50,000
Maximum [Member] | Chief Financial Officer And Treasurer [Member]
Commitments And Contingencies [Line Items]
Employee relocation related expenses	10,000
Scenario, Forecast [Member] | Chief Financial Officer And Treasurer [Member]
Commitments And Contingencies [Line Items]
Annual base salary	335,000
Scenario, Forecast [Member] | Senior Vice President, Business Development [Member]
Commitments And Contingencies [Line Items]
Annual base salary	292,000
Scenario, Forecast [Member] | President and Chief Executive Officer [Member]
Commitments And Contingencies [Line Items]
Annual base salary	410,000
Scenario, Forecast [Member] | Senior Vice President, General Counsel and Secretary [Member]
Commitments And Contingencies [Line Items]
Annual base salary	$234,000
Hopewell Junction, New York [Member]
Commitments And Contingencies [Line Items]
Area of leased real estate property	37,000
Lease expiration date	1-May-19
Bellevue, Washington [Member]
Commitments And Contingencies [Line Items]
Area of leased real estate property	1,500
Santa Clara, California [Member]
Commitments And Contingencies [Line Items]
Area of leased real estate property	1,800
Lease expiration date	1-Oct-15

Concentrations_Narrative_Detai

Concentrations (Narrative) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
	customer	customer
Two Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of customers		2
Ten Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of customers	10	10
Accounts Receivable [Member] | Two Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concetration of risk percentage		17.00%
Accounts Receivable [Member] | Ten Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concetration of risk percentage	78.00%	70.00%
Accounts Receivable [Member] | Three Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of customers	3
Concetration of risk percentage	44.00%
Accounts Receivable [Member] | Two Additional Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of customers		2
Concetration of risk percentage		26.00%
Sales Revenue, Net [Member] | Two Customers [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concetration of risk percentage		22.00%

Concentrations_Schedule_Of_Rev

Concentrations (Schedule Of Revenue By Geographic Location) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$6,720	$5,699	$7,018	$6,278	$6,130	$6,329	$7,028	$8,503	$25,715	$27,990
North And South America [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									13,560	17,674
Europe, Middle East, And Africa [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									9,246	7,632
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									$2,909	$2,684
Sales Revenue, Net [Member] | Domestic [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concetration of risk percentage									51.00%	62.00%
Sales Revenue, Net [Member] | International [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concetration of risk percentage									49.00%	38.00%

Quarterly_Financial_Informatio2

Quarterly Financial Information Disclosure (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Information [Abstract]
Revenues	$6,720	$5,699	$7,018	$6,278	$6,130	$6,329	$7,028	$8,503	$25,715	$27,990
Gross profit	1,539	1,745	2,169	1,931	59	2,225	2,391	3,751	7,385	8,426
Net (loss) income before income tax	-1,556	-1,036	-1,047	-1,618	-3,323	-1,057	-1,128	325	-5,257	-5,183
Net loss	($1,556)	($1,036)	($1,047)	($1,618)	($8,705)	($4,559)	($1,008)	$205	($5,257)	($14,067)
Net (loss) income per share - basic	($0.07)	($0.04)	($0.04)	($0.07)	($0.37)	($0.19)	($0.04)	$0.01	($0.22)	($0.60)
Net (loss) income per share - diluted	($0.07)	($0.04)	($0.04)	($0.07)	($0.37)	($0.19)	($0.04)	$0.01	($0.22)	($0.60)
Weighted average number of shares outstanding - basic	24,943,181	24,842,945	23,940,800	23,778,110	23,726,626	23,718,106	23,586,413	23,527,072	24,376,259	23,639,554
Weighted average number of shares outstanding - diluted	24,943,181	24,842,945	23,940,800	23,778,110	23,726,626	23,718,106	23,586,413	25,332,976	24,376,259	23,639,554